Explore evidence

211 individualsAmong 348 women in a 2-year study of young women at high HIV risk in Thika and Kisumu, Kenya, 211 (61%) followed a low and declining PrEP adherence trajectory.

KenyaVIH/sidapublished 2023AIDS and behaviorPubMeddocument of 5 observations

5.8 per_100_person_yearsIn uMkhanyakude, HIV incidence among 20- to 24-year-old females was 5.8 new infections per 100 person-years in the pre-DREAMS period.

KenyaVIH/sidapublished 2021PLoS medicinePubMeddocument of 7 observations

1.1 risk_ratioThe intervention had a risk ratio of 1.10 for virological suppression at 2 years compared with standard care.

KenyaVIH/sidapublished 2023The lancet. HIVPubMeddocument of 8 observations

76 %Among viral failures with CD4 <100 cells/µL, 76.0% in Kenya were on ineffective antiretroviral therapy regimens.

KenyaVIH/sidapublished 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 14 observations

The prevalence of infrequent condom use declined in Kenya between 2010 and 2019.

KenyaVIH/sidaobserved 2010–2019published 2022The Lancet. Global healthPubMeddocument of 7 observations

93 %Among 284 HIV-positive sex partners, 264 (93%) returned at 6 weeks.

KenyaVIH/sidapublished 2020Sexually transmitted diseasesPubMeddocument of 4 observations

94 %Of the 674 women who selected clinic-based rapid diagnostic blood tests for HIV, 595 (94%) retested using that method.

KenyaVIH/sidaobserved November 2017 to June 2019published 2024PloS onePubMeddocument of 5 observations

80.6 %The TMP intervention achieved 80.6% of persons living with HIV who were diagnosed being on treatment.

KenyaVIH/sidapublished 2022Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 9 observations

14 %People who inject drugs in Kenya have HIV prevalence ranging from 14% to 26% across settings.

KenyaVIH/sidapublished 2022AIDS (London, England)PubMeddocument of 8 observations

89 %Among women living with HIV initiating dolutegravir-containing antiretroviral treatment in Kenya from 2017 to 2020, 89% initiated dolutegravir after transitioning from a non-nucleoside reverse transcriptase inhibitor.

KenyaVIH/sidaobserved 2017 to 2020published 2022Journal of the International AIDS SocietyPubMeddocument of 10 observations

0.45 odds_ratioAt endline, adolescent girls and young women (AGYW) in intervention households had less food insecurity than those in control households, with an odds ratio of 0.45 (95% CI 0.21 to 0.97; p=0.04).

KenyaVIH/sidapublished 2026BMJ global healthPubMeddocument of 9 observations

15,183 okay-responsesAmong 299 pregnant women living with HIV in Kenya, 15,183 (48%) okay-responses and 438 (1%) problem-responses were sent to interactive text messages during the intervention period.

KenyaVIH/sidapublished 2024BMC pregnancy and childbirthPubMeddocument of 6 observations

0.4 ratioIn adjusted analyses, HIV prevalence among female sex workers accessing SWOP clinics in Nairobi in 2016 was associated with an adjusted prevalence ratio of 0.40 compared with 2008.

KenyaVIH/sidaobserved 2016published 2021AIDS (London, England)PubMeddocument of 13 observations

11 %Among people living with HIV in Kibera, 11% of those who missed medications cited government measures as a reason.

KenyaVIH/sidapublished 2021International journal of environmental research and public healthPubMeddocument of 7 observations

36.8 %36.8% of HIV-negative adolescent girls and young women were identified as high risk.

KenyaVIH/sidaobserved 2017-2018published 2021The Journal of adolescent health : official publication of the Society for Adolescent MediPubMeddocument of 8 observations

1,500 clientsFrom March to June 2022, 1500 pharmacy clients completed HIV testing and were referred to clinic-based HIV services.

KenyaVIH/sidaobserved March to June 2022published 2025BMC health services researchPubMeddocument of 13 observations

14 monthsAmong 299 pregnant women living with HIV in Kenya, the proportion of non-responses increased with time and exceeded 50% around 14 months from enrolment.

KenyaVIH/sidapublished 2024BMC pregnancy and childbirthPubMeddocument of 6 observations

10.6 %The prevalence of HIV infection among patients with cancer was 10.6% (32 of 301) in a cohort attending a tertiary hospital in Nairobi, Kenya, between February 2021 and September 2021.

KenyaVIH/sidaobserved February 2021 to September 2021published 2023JCO global oncologyPubMeddocument of 8 observations

7.3 %HIV prevalence was 7.3% among adolescent girls and young women recruited at nonvenues in Mombasa, Kenya.

KenyaVIH/sidapublished 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 6 observations

52.4 %Testing eligible partners in key populations decreased from 52.4% (183/349) to 40.7% (109/268) between year 1 and year 2 of index testing implementation in Nairobi County.

KenyaVIH/sidapublished 2023Tropical medicine & international health : TM & IHPubMeddocument of 8 observations

44.51 %The gender-based adjusted HIV prevalence among women who inject drugs was 44.51%.

KenyaVIH/sidapublished 2021BMC public healthPubMeddocument of 17 observations

0.64 per_100_person_yearsIn Gem, HIV incidence among 20- to 24-year-old females was 0.64 new infections per 100 person-years during DREAMS implementation.

KenyaVIH/sidapublished 2021PLoS medicinePubMeddocument of 7 observations

16 %Prevalence of hypertension among persons with HIV on long-term antiretroviral therapy was 16%.

Kenyahypertension artérielle · VIH/sidaobserved September 2017 to May 2018published 2022PloS onePubMeddocument of 6 observations

96 %96% of HIV self-testing acceptors said they would use HIV self-testing in the future, compared to 76% of decliners.

KenyaVIH/sidapublished 2020Journal of the International AIDS SocietyPubMeddocument of 7 observations

5.3 relative_riskMothers unaware of their partners’ HIV status had a relative risk of 5.3 for infant HIV positivity at 6 weeks.

KenyaVIH/sidaobserved 6 weekspublished 2023European Journal of Public HealthOpenAlexdocument of 7 observationsDOI 10.1093/eurpub/ckad160.824